64.23
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
ROSEN, THE FIRST FILING FIRM, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Advances Fainting Detection Study With New Wearable Data Initiative - TipRanks
Boston Scientific Corporation $BSX Position Lifted by Ninety One UK Ltd - MarketBeat
Asset Management One Co. Ltd. Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
AE Wealth Management LLC Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionBSX - TMX Newsfile
Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings - Insider Monkey
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Boston Scientific: The Company That Never Turned Around - Yahoo
Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026 - Insider Monkey
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth - marketscreener.com
Boston Scientific Corporation $BSX Position Increased by KBC Group NV - MarketBeat
Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corp (BSX-N) Stock Price and News - The Globe and Mail
Truist cuts Boston Scientific stock price target on Watchman concerns By Investing.com - Investing.com South Africa
Truist cuts Boston Scientific stock price target on Watchman concerns - Investing.com
BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Truist Financial Cuts Boston Scientific (NYSE:BSX) Price Target to $90.00 - MarketBeat
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Baird Adjusts Boston Scientific Price Target to $86 From $95, Maintains Outperform Rating - marketscreener.com
Truist Trims Price Target on Boston Scientific to $90 From $92, Keeps Buy Rating - marketscreener.com
Boston Scientific invests €75m in Galway site - Business Post
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX - ChartMill
Boston Scientific Corp. stock rises Tuesday, still underperforms market - MarketWatch
Cardiac Monitoring Devices Market Set for Sustained Growth at 5.17% CAGR Through 2034: DelveInsight | Philips, Medtronic, and Boston Scientific - Barchart.com
Citi Reiterates Buy rating for Boston Scientific (BSX) - Yahoo Finance
Boston Scientific Corp. stock (US10117L1017): Is medtech innovation strong enough to unlock new upsi - AD HOC NEWS
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile
Fund Update: 486,715 BOSTON SCIENTIFIC (BSX) shares added to Bank Pictet & Cie (Europe) AG portfolio - Quiver Quantitative
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - Barchart.com
RBC Cuts Price Target on Boston Scientific to $105 From $115, Keeps Outperform Rating - marketscreener.com
Faruqi & Faruqi, LLP Highlights Class Action Against Boston Scientific (BSX) and Upcoming Lead Plaintiff Deadline of May 4, 2026 - marketscreener.com
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific Corporation $BSX Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Boston Scientific Corp. stock (US10117L1017): Is its medtech innovation edge strong enough to drive - AD HOC NEWS
BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Sowell Financial Services LLC Sells 21,713 Shares of Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific's big dip could be a bigger opportunity - MSN
BSX Price History for Boston Scientific Corp Stock - Barchart
Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System - Insider Monkey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT - GlobeNewswire
Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific Faces Class Action Lawsuit from Shareholders - Intellectia AI
BSX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Deals tracker: Orlando Health to acquire Alabama health system - Modern Healthcare
Boston Scientific Neuromodulation Lawsuit Claims Spinal Cord Stimulator Exacerbated Chronic Pain - AboutLawsuits.com
Boston Scientific Corporation (NYSE:BSX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Fidelity Advisor Global Capital Appreciation Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile
Leerink Reiterates Outperform on Boston Scientific (BSX) After CHAMPION-AF Readout - Insider Monkey
Boston Scientific stock hits 52-week low at 61.23 USD By Investing.com - Investing.com Australia
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):